Milgrom Lionel R
Department of Chemistry, Imperial College of Science, Technology and Medicine, London, United Kingdom.
J Altern Complement Med. 2005 Oct;11(5):831-8. doi: 10.1089/acm.2005.11.831.
Randomized controlled trials (RCTs) have yet to deliver unequivocal results demonstrating the efficacy (or otherwise) of homeopathic remedies and individualized homeopathic prescribing. This could be caused by an implicit assumption inherent in RCT methodology that specific effects of a remedy and any nonspecific effects of consultation are independent of each other. Reported here is a theoretical investigation of the consequences arising from this assumption proving to be false.
A previously developed theoretical model of entanglement in homeopathy between patient, practitioner, and remedy (called PPR entanglement) was used in this investigation.
The adherence to RCT methodology could result in such trials completely disrupting the formation or survival of any three-way PPR entangled state.
Assuming the PPR entangled state is a necessary condition for therapeutic interaction, alternatives to RCTs are urgently required that can take into account possible entangled specific and nonspecific effects during trials of homeopathy. That RCTs sometimes deliver positive results for the use of homeopathic remedies may be caused by residual entanglement arising from homeopathic remedy manufacture.
随机对照试验(RCTs)尚未得出明确结果来证明顺势疗法药物及个体化顺势疗法处方的疗效(或反之)。这可能是由于RCT方法中固有的一个隐含假设,即药物的特定效应与咨询的任何非特定效应相互独立。本文报告了一项理论研究,该研究表明这一假设被证明是错误时所产生的后果。
本研究使用了先前开发的一个关于顺势疗法中患者、从业者和药物之间纠缠的理论模型(称为PPR纠缠)。
坚持RCT方法可能导致此类试验完全破坏任何三方PPR纠缠态的形成或存续。
假设PPR纠缠态是治疗相互作用的必要条件,那么迫切需要RCT的替代方法,这些方法在顺势疗法试验期间能够考虑到可能的纠缠特定效应和非特定效应。RCT有时得出使用顺势疗法药物的阳性结果,可能是由于顺势疗法药物制造产生的残余纠缠所致。